BCORL1
Basic information
Region (hg38): X:129981107-130058071
Previous symbols: [ "CXorf10" ]
Links
Phenotypes
GenCC
Source:
- Shukla-Vernon syndrome (Limited), mode of inheritance: XL
- syndromic intellectual disability (Supportive), mode of inheritance: AD
- Shukla-Vernon syndrome (Limited), mode of inheritance: XL
- Shukla-Vernon syndrome (Strong), mode of inheritance: XL
- Shukla-Vernon syndrome (Limited), mode of inheritance: XL
- Shukla-Vernon syndrome (Limited), mode of inheritance: XL
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Shukla-Vernon syndrome | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 24123876; 30941876 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (246 variants)
- not_specified (105 variants)
- Shukla-Vernon_syndrome (58 variants)
- BCORL1-related_disorder (38 variants)
- See_cases (3 variants)
- Oligoasthenoteratozoospermia (2 variants)
- Multiple_myeloma (1 variants)
- Neurodevelopmental_disorder (1 variants)
- Global_developmental_delay (1 variants)
- Neurodevelopmental_delay (1 variants)
- Intellectual_disability (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCORL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001379451.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 41 | 11 | 53 | |||
| missense | 298 | 27 | 330 | |||
| nonsense | 7 | |||||
| start loss | 0 | |||||
| frameshift | 8 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 3 | 4 | 312 | 68 | 12 |
Highest pathogenic variant AF is 0.00008525424
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| BCORL1 | protein_coding | protein_coding | ENST00000540052 | 12 | 76976 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 0.00000917 | 125697 | 5 | 6 | 125708 | 0.0000438 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.06 | 581 | 739 | 0.786 | 0.0000624 | 10997 |
| Missense in Polyphen | 124 | 222.97 | 0.55613 | 3368 | ||
| Synonymous | 1.02 | 302 | 325 | 0.928 | 0.0000297 | 3783 |
| Loss of Function | 5.67 | 2 | 41.4 | 0.0483 | 0.00000350 | 623 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000223 | 0.000208 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000579 | 0.000217 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000130 | 0.00000879 |
| Middle Eastern | 0.000579 | 0.000217 |
| South Asian | 0.00 | 0.00 |
| Other | 0.000255 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional corepressor. May specifically inhibit gene expression when recruited to promoter regions by sequence- specific DNA-binding proteins such as BCL6. This repression may be mediated at least in part by histone deacetylase activities which can associate with this corepressor. {ECO:0000269|PubMed:17379597}.;
- Pathway
- Mesodermal Commitment Pathway;Pathways Affected in Adenoid Cystic Carcinoma
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.338
- rvis_EVS
- -2.12
- rvis_percentile_EVS
- 1.52
Haploinsufficiency Scores
- pHI
- 0.193
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.628
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.670
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bcorl1
- Phenotype
Gene ontology
- Biological process
- chromatin organization
- Cellular component
- nucleoplasm;plasma membrane
- Molecular function